Quattro Financial Advisors’s Moderna MRNA Stock Holding History

Quattro Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Hold	25,000	–	–	0.38%	53
2025 Q4	$737K	Hold	25,000	–	–	0.22%	60
2025 Q3	$646K	Hold	25,000	–	–	0.2%	62
2025 Q2	$690K	Hold	25,000	–	–	0.24%	55
2025 Q1	$709K	Sell	25,000 -59,600	-70%	-$2.11M	0.24%	57
2024 Q4	$3.44M	Buy	84,600 +22,500	+36%	+$1.08M	0.89%	25
2024 Q3	$3.63M	Sell	62,100 -25,000	-29%	-$2.3M	1.02%	27
2024 Q2	$10.3M	Hold	87,100	–	–	2.71%	11
2024 Q1	$9.28M	Buy	87,100 +87,001	+87,880%	+$8.77M	2.64%	11
2023 Q4	$7.7M	Sell	99 -57,201	-100%	-$4.81M	2.66%	10
2023 Q3	$5.92M	Buy	57,300 +37,300	+187%	+$4.16M	2.58%	12
2023 Q2	$2.43M	Buy	20,000 +10,000	+100%	+$1.33M	0.97%	27
2023 Q1	$1.54M	Buy	10,000 +5,000	+100%	+$825K	0.63%	33
2022 Q4	$898K	Sell	5,000 -5,000	-50%	-$818K	0.36%	45
2022 Q3	$1.18M	Hold	10,000	–	–	0.47%	35
2022 Q2	$1.43M	Buy	+10,000	New	+$1.43M	0.49%	36

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return